The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
Main Authors: | Brennan Marsh-Armstrong, Jesse M. Fajnzylber, Samuel Korntner, Bailey A. Plaman, Anthony C. Bishop |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2018-11-01
|
Series: | ACS Omega |
Online Access: | http://dx.doi.org/10.1021/acsomega.8b02200 |
Similar Items
-
The role of the protein tyrosine phosphatase SHP2 in T cell signalling
by: Bailey, C. R. J.
Published: (2002) -
Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations
by: Quan Wang, et al.
Published: (2020-11-01) -
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
by: Ricardo A. P. Pádua, et al.
Published: (2018-10-01) -
Tau associates with protein tyrosine phosphatase SHP2
by: Kim, Yohan
Published: (2017) -
Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase
by: Adrienn Markovics, et al.
Published: (2020-06-01)